(Q37608586)

21 August 2017

title

Potential of adiponectin as a cardioprotective agent (English)

1 reference

21 August 2017

Rei Shibata

1

1 reference

21 August 2017

Noriyuki Ouchi

series ordinal

2

1 reference

21 August 2017

Kenneth Walsh

series ordinal

3

1 reference

21 August 2017

Toyoaki Murohara

series ordinal

4

1 reference

21 August 2017

publication date

1 November 2007

1 reference

21 August 2017

1 reference

21 August 2017

volume

3

1 reference

21 August 2017

issue

6

1 reference

21 August 2017

page(s)

647-656

1 reference

A war on obesity, not the obese.

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

The metabolic syndrome: more than the sum of its parts?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Obesity, adiponectin and vascular inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Adipose tissue, inflammation, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

AdipoQ is a novel adipose-specific gene dysregulated in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Disturbed secretion of mutant adiponectin associated with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Adiponectin as a biomarker of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Adiponectin and development of type 2 diabetes in the Pima Indian population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Adiponectin and protection against type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Plasma adiponectin is an independent predictor of type 2 diabetes in Asian indians

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Adiponectin, an adipocyte-derived protein, predicts future insulin resistance: two-year follow-up study in Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Hypoadiponectinemia is an independent risk factor for hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Implications of plasma concentrations of adiponectin in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

The variation of plasma concentrations of a novel, adipocyte derived protein, adiponectin, in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Plasma adiponectin levels and risk of myocardial infarction in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Adiponectin and future coronary heart disease events among men with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Possible impairment of transcardiac utilization of adiponectin in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Transcardiac adiponectin gradient is independently related to endothelial vasomotor function in large and resistance coronary arteries in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Associations among plasma adiponectin, hypertension, left ventricular diastolic function and left ventricular mass index.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Circulating adiponectin concentrations in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Insights into the pathogenesis of chronic heart failure: immune activation and cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Adiponectin inhibits endothelial synthesis of interleukin-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Disruption of adiponectin causes insulin resistance and neointimal formation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Magnetically driven plasmid DNA delivery with biodegradable polymeric nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Statins augment collateral growth in response to ischemia but they do not promote cancer and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Adiponectin stimulates production of nitric oxide in vascular endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Globular adiponectin upregulates nitric oxide production in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Association of hypoadiponectinemia with impaired vasoreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Relationship of impaired glucose tolerance to left ventricular structure and function: The Strong Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Adiponectin-mediated modulation of hypertrophic signals in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Exacerbation of heart failure in adiponectin-deficient mice due to impaired regulation of AMPK and glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Role of adiponectin receptors in endothelin-induced cellular hypertrophy in cultured cardiomyocytes and their expression in infarcted heart

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Adiponectin is synthesized and secreted by human and murine cardiomyocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Globular adiponectin activates nuclear factor-kappaB and activating protein-1 and enhances angiotensin II-induced proliferation in cardiac fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Body mass index: a risk factor for unstable angina and myocardial infarction in patients with angiographically confirmed coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

AMP-activated protein kinase activates p38 mitogen-activated protein kinase by increasing recruitment of p38 MAPK to TAB1 in the ischemic heart

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

AMP-activated protein kinase protects cardiomyocytes against hypoxic injury through attenuation of endoplasmic reticulum stress

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Cyclooxygenase-1 and -2 knockout mice demonstrate increased cardiac ischemia/reperfusion injury but are protected by acute preconditioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Prostaglandin E2 protects the heart from ischemia-reperfusion injury via its receptor subtype EP4.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Reduction of infarct size by selective stimulation of prostaglandin EP(3)receptors in the reperfused ischemic pig heart

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Adiponectin replacement therapy attenuates myocardial damage in leptin-deficient mice with viral myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Adiponectin protects against the development of systolic dysfunction following myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Expression of adiponectin and its receptors in swine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Calreticulin in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Adiponectin and its receptors are expressed in adult ventricular cardiomyocytes and upregulated by activation of peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Change in expression of GBP28/adiponectin in carbon tetrachloride-administrated mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Induction of adiponectin in skeletal muscle of type 2 diabetic mice: In vivo and in vitro studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Inhibition of cyclooxygenase-2 enhances myocardial damage in a mouse model of viral myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Impaired expression of cardiac adiponectin in leptin-deficient mice with viral myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Genomic expression profiling of human inflammatory cardiomyopathy (DCMi) suggests novel therapeutic targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

Adiponectin and Coronary Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.6.647

21 January 2018

Identifiers

DOI

10.2217/14796678.3.6.647

1 reference

21 August 2017

1 reference